Jiangsu Sihuan Bioengineering Co., Ltd

¥3.08As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000518Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (9.24%)
Div yield —
ROE (21.85%)
Biotechnology
Beta (5Y) 0.39
PE TTM —
TSR TTM 25.20%
Mkt cap ¥3.171B
ROIC (26.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥3.43
11.48%
(92.05%)
Hold 8|11|9|9|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.08
0.09
41.49%
42.51%
47.05%
42.19%
Revenue¥M
159.3
159.0
156.7
153.3
0.79%
(1.47%)
(1.11%)
(5.05%)
Peers (US$475.3M)
Cap (US$)
PE
478.7M
30.07x
462.3M
43.75x
Capital
TTM
5Y
10Y
Leveragex
1.423
1.461
1.130
EBIT/Intx
2.222
0.317
0.309
Own earn%
78.60
(247.82)
(220.08)
Sh yield%
51.12
25.70
24.90
Owners
Insiders/Inst%
10.30
53.05
Short interest%
2.50
SBC / revenue%
4.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
9